Cargando…
A Brief Review on The Molecular Basis of Medullary Thyroid Carcinoma
Approximately 5-10% of all thyroid cancers are medullary thyroid carcinomas (MTC). MTC is mainly sporadic in nature, but 20-30% of cases are hereditary. Genetic testing for hereditary MTC is very important for the patient and his family, but the patients must be receiving appropriate genetic counsel...
Autores principales: | Mohammadi, Masoumeh, Hedayati, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086327/ https://www.ncbi.nlm.nih.gov/pubmed/28042533 |
Ejemplares similares
-
Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms
por: Ceolin, Lucieli, et al.
Publicado: (2011) -
Ceruloplasmin Status in Medullary Thyroid Carcinoma
por: RAZAVI, Fatemeh, et al.
Publicado: (2020) -
Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET
por: Sahakian, Nicolas, et al.
Publicado: (2023) -
Management of medullary carcinoma of the thyroid: a
review
por: Jayasinghe, Ravindri, et al.
Publicado: (2022) -
Melanotic medullary carcinoma of thyroid – report of a rare case with brief review of literature
por: Singh, Kamaljeet, et al.
Publicado: (2008)